Latest Updates on Gaucher Disease Treatment Options

 

Gaucher Disease Treatment

What is Gaucher Disease?

Gaucher disease is a rare inherited disorder that affects certain cells in the body called macrophages. Macrophages are a type of white blood cell that helps fight infection and keeps tissues healthy. In people with Gaucher disease, a fatty substance called glucosylceramide builds up inside macrophages in certain organs and tissues, including the liver, spleen, bone marrow, and sometimes the lungs or brain. There are three main types of Gaucher disease - type 1, type 2, and type 3 - based on whether the person has neurological symptoms and the severity of symptoms.

Types of Gaucher Disease:

Type 1 Gaucher Disease: This is the most common type. People with type 1 Gaucher disease don't have neurological symptoms. Symptoms may include enlarged spleen and liver, low blood cell counts, bone problems like joint pain and fractures.

Type 2 Gaucher Disease: This is the most severe type and is a neurological form of Gaucher disease. Symptoms usually appear before age 2 and progression is very rapid. Symptoms include rapid enlargement of the liver and spleen, lung disease, severe brain dysfunction, and death usually occurs by age 2.

Type 3 Gaucher Disease: This type has a variable presentation in between type 1 and type 2. Neurological symptoms develop later than in type 2 usually after age 2. Progression is slower than type 2 but faster than type 1. Organ involvement such as liver and spleen enlargement is also seen.

Gaucher Disease Treatment Options:

Enzyme Replacement Therapy: Enzyme replacement therapy (ERT) provides the missing or deficient enzyme that is not working properly in Gaucher Disease. Three drugs are available for ERT - alglucerase (Ceredase), imiglucerase (Cerezyme), and velaglucerase alfa (Vpriv). These drugs are infused intravenously every 2 weeks and help reduce organ enlargement and improvement in blood cell counts. ERT does not treat neurological symptoms.

Substrate Reduction Therapy: Substrate reduction therapy uses a drug called eliglustat (Cerdelga) which is taken orally to reduce the amount of substrate that builds up in Gaucher cells. This helps reduce organ and spleen size and improve blood cell counts. It is only FDA approved for adults with type 1 Gaucher disease.

Bone Marrow Transplant: A bone marrow transplant replaces the person's diseased bone marrow with healthy donor bone marrow. It can potentially cure type 1 disease but due to risks, it is only considered for severe symptomatic type 3 disease without effective ERT or when ERT has failed. Success depends on donor matching and age of the patient.

For bone disease, additional treatments like bisphosphonates may be used. Physical and occupational therapy can help improve mobility and prevent further bone problems. Splenectomy may be considered in severe splenomegaly. Careful monitoring by a medical team is needed.

Clinical Trials for New Gaucher Disease Treatment Options:

Several new drugs and techniques are being evaluated in clinical trials for better treatment of Gaucher disease:

- Venglustat: An oral substrate reduction therapy similar to eliglustat but may have fewer food interaction issues. Phase 3 trials are underway.

- Arimoclomol: Acts by stimulating heat shock proteins to help damaged cells. Phase 2 trials showed reduction in spleen and liver volumes.

- Gene Therapy: Still in preclinical testing, aims to deliver corrective gene directly into patients' cells through vectors to provide long term effects.

- Antisense Oligonucleotides: Uses synthetic anti-sense RNA strands that bind to messenger RNA involved in pathogenic processes and modulate gene expression. Phase 1/2 trials ongoing.

- Stem Cell Therapy: Use of gene-corrected stem cells from patient's own bone marrow or cord blood through transplantation aims to permanently correct the genetic defect. Early research phase.

- Telotristat Etiprate: Reduces production of substrate that accumulate in Gaucher cells, in addition to approved therapies. Approved for neuroendocrine tumor symptoms. Studies in Gaucher disease.

In summary, gaucher disease treatment has advanced significantly over the last few decades. Enzyme replacement therapy is the standard treatment for type 1 Gaucher disease and provides considerable benefit. Substrate reduction therapy is also available. However, new promising treatment options through targeted gene modulation or gene therapy may potentially provide cure in future through a single treatment course. Careful monitoring and multidisciplinary care approach is important for optimal outcome.

 

Get more insights on Gaucher Disease Treatment

 

About Author

Priya Pandey, is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement.

(LinkedIn- https://www.linkedin.com/in/priya-pandey-8417a8173/)

Comments

Post a Comment

Popular posts from this blog

Dolomite: A promising mineral for construction and agriculture industries

Image
Importance of Dolomite in construction Dolomite is one of the primary minerals used in construction industry globally. It is mainly used as an aggregate in road construction, concrete production and railway ballast. Dolomite aggregate is widely used in road construction due to its ability to withstand pressure and impact. Its high strength and durability makes it a suitable material for constructing highways, roads and bridges. Being resistant to weathering, dolomite roads last longer compared to other aggregates. Apart from aggregates, Dolomite is also used as a fluxing agent during steel manufacturing. Finely powdered dolomite is mixed with other fluxing materials in steel furnaces. The calcium-magnesium content of dolomite lowers the melting point and viscosity of slag, facilitating the steel making process. Dolomite flux also improves the fluidity and protects refractory linings of blast furnaces and basic oxygen furnaces. Another major construction application of dolomite is i...
Read more

Endocrine Therapy Drugs: The Future of Cancer Treatment

Image
Endocrine therapy drugs (ETDs) have emerged as a breakthrough in the treatment of hormone-receptor positive cancers like breast, prostate and gynecological cancers. These targeted drugs work by blocking the effects of certain hormones like estrogen and progesterone that fuel the growth of cancer cells. With continuous advancements in research, ETDs are revolutionizing cancer management and improving outcomes for millions of patients worldwide. Types of ETDs A wide range of ETDs are available today which can be broadly classified into following categories: Aromatase Inhibitors Aromatase inhibitors like anastrozole, letrozole and exemestane work by blocking the enzyme aromatase which is responsible for the formation of estrogen in tissues. By reducing estrogen levels in the body, these drugs deprive hormone receptor positive breast cancer cells of the fuel required for their growth and proliferation. They are primarily used in postmenopausal women as a treatment for hormone recept...
Read more

The Toxic Chemical Lurking in Our Daily Products: The Issue of Bisphenol A

Image
 Bisphenol A: An Overview Bisphenol A, commonly known as BPA, is a synthetic chemical that is primarily used in the production of polycarbonate plastics and epoxy resins. First developed in 1891, BPA acts as a monomer in the production of plastics and resins. These materials provide strength, durability and clarity to a wide range of products. However, over time, studies have linked BPA exposure to several health risks in both humans and animals. Prevalence in Daily Life BPA is highly prevalent in our daily lives due to its use in a variety of common consumer products and food containers. It is found in hard, clear plastic bottles for water as well as plastic containers and packaging for various canned and frozen foods. The chemical is also used in dental sealants and coatings on metal products like food cans. Even thermal paper commonly used for printing sales receipts contains BPA and leads to human exposure. The widespread use of BPA means humans are regularly exposed through ...
Read more